{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:51:35Z","timestamp":1791319895666,"version":"4.3.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium fur Bildung und Forschung Dienststelle Bonn","doi-asserted-by":"publisher","award":["GO-Bio grant II"],"award-info":[{"award-number":["GO-Bio grant II"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.08.054","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T06:02:53Z","timestamp":1788156173000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gp120-Activated Allogeneic Regulatory T cells for Prevention of Graft-versus-Host-Disease: A First-in-Human Trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-6568","authenticated-orcid":false,"given":"Andrea","family":"Tuettenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Ruhnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Schl\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"R\u00fccker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Wehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Epp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietlinde","family":"Janson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Wetzko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Reicherts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-3029","authenticated-orcid":false,"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-3393","authenticated-orcid":false,"given":"Robert","family":"Zeiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9331-5145","authenticated-orcid":false,"given":"Matthias","family":"Stelljes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf Georg","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wermke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Wagner-Drouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5672-9365","authenticated-orcid":false,"given":"Helmut","family":"Jonuleit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jtct.2026.08.054_bib0001","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jtct.2025.05.014","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy: a report from the CIBMTR","volume":"31","author":"Spellman","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"17","key":"10.1016\/j.jtct.2026.08.054_bib0002","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.054_bib0003","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","article-title":"The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT","volume":"60","author":"Passweg","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.054_bib0004","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.hemonc.2017.05.007","article-title":"Current indication for hematopoietic cell transplantation in adults","volume":"10","author":"Okamoto","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"22","key":"10.1016\/j.jtct.2026.08.054_bib0005","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease: biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jtct.2026.08.054_bib0006","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.054_bib0007","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41375-020-0804-2","article-title":"Treatment and unmet needs in steroid-refractory acute graft-versus-host disease","volume":"34","author":"Malard","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2026.08.054_bib0008","series-title":"The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies [Internet]","author":"Holler","year":"2024"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.054_bib0009","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41409-022-01764-w","article-title":"Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review","volume":"57","author":"Holtan","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"18","key":"10.1016\/j.jtct.2026.08.054_bib0010","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.2024026446","article-title":"Donor regulatory T-cell therapy to prevent graft-versus-host disease","volume":"145","author":"Meyer","year":"2025","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.054_bib0011","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.2023020073","article-title":"Novel developments in the prophylaxis and treatment of acute GVHD","volume":"142","author":"Jamy","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.054_bib0012","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.2021015129","article-title":"How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond","volume":"141","author":"Rimando","year":"2023","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.054_bib0013","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127244","article-title":"Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients","volume":"4","author":"Meyer","year":"2019","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.054_bib0014","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood.2025031313","article-title":"Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial","volume":"147","author":"Meyer","year":"2026","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.jtct.2026.08.054_bib0015","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1182\/blood-2013-08-453126","article-title":"Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation","volume":"122","author":"Schneidawind","year":"2013","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jtct.2026.08.054_bib0016","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"issue":"83","key":"10.1016\/j.jtct.2026.08.054_bib0017","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.054_bib0018","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.054_bib0019","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood-2009-02-206730","article-title":"Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells","volume":"114","author":"Becker","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.054_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020271","article-title":"Dimethyl fumarate therapy significantly improves the responsiveness of T cells in multiple sclerosis patients for immunoregulation by regulatory T cells","volume":"18","author":"Schl\u00f6der","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.054_bib0021","doi-asserted-by":"crossref","first-page":"16330","DOI":"10.3390\/ijms160716330","article-title":"Interferon-beta therapy of multiple sclerosis patients improves the responsiveness of T cells for immune suppression by regulatory T cells","volume":"16","author":"Trinschek","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtct.2026.08.054_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1604483","article-title":"Treg cell therapy manufacturability: current state of the art, challenges and new opportunities","volume":"16","author":"Stoops","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2026.08.054_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.751590","article-title":"Strong expansion of human regulatory T cells for adoptive cell therapy results in epigenetic changes which may impact their survival and function","volume":"9","author":"Ou","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.054_bib0025","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltad007","article-title":"Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective","volume":"3","author":"Sakaguchi","year":"2023","journal-title":"Immunother Adv"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.054_bib0026","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.054_bib0027","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4049\/jimmunol.1402861","article-title":"Donor requirements for regulatory T cell suppression of murine graft-versus-host disease","volume":"195","author":"Pierini","year":"2015","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.054_bib0028","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial","volume":"10","author":"Finke","year":"2009","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.054_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130026","article-title":"Impact of pre-transplant anti-T cell globulin (ATG) on immune recovery after myeloablative allogeneic peripheral blood stem cell transplantation","volume":"10","author":"Servais","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.054_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173088","article-title":"Differential depletion of total T cells and regulatory T cells and prolonged allotransplant survival in CD3\u0190 humanized mice treated with polyclonal anti human thymocyte globulin","volume":"12","author":"Buszko","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2026.08.054_bib0031","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2172-13-70","article-title":"Anti-thymocyte globulin (ATG) differentially depletes na\u00efve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice","volume":"13","author":"Xia","year":"2012","journal-title":"BMC Immunol"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.054_bib0032","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1084\/jem.20020033","article-title":"Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells","volume":"195","author":"Goldrath","year":"2002","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.054_bib0033","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.192.9.1213","article-title":"Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells","volume":"192","author":"Jonuleit","year":"2000","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.054_bib0034","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43372-2","article-title":"Data-driven grading of acute graft-versus-host disease","volume":"14","author":"Bayraktar","year":"2023","journal-title":"Nat Commun"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:04:52Z","timestamp":1791317092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726006950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S2666636726006950"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.054","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gp120-Activated Allogeneic Regulatory T cells for Prevention of Graft-versus-Host-Disease: A First-in-Human Trial","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}